banner2

Getting started
D-Mannosamine Hydrochloride CAS 5505-63-5

D-Mannosamine Hydrochloride CAS 5505-63-5 - Manufacturers, Suppliers, Factory from China

D-Mannosamine Hydrochloride CAS 5505-63-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Xylazine Hydrochloride CAS 23076-35-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Xylazine Hydrochloride CAS 23076-35-9 Assay 98.0%-102.0% High Purity
Read More

Azetidine Hydrochloride CAS 36520-39-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Azetidine Hydrochloride CAS 36520-39-5 Assay ≥98.0% (HPLC)

cis-4-Hydroxy-D-Proline Hydrochloride CAS 77449-94-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — cis-4-Hydroxy-D-Proline Hydrochloride CAS 77449-94-6 Assay ≥98.0% (HPLC)

Glycine Ethyl Ester Hydrochloride CAS 623-33-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Glycine Ethyl Ester Hydrochloride CAS 623-33-6 Purity ≥99.0% (HPLC)

β-Alanine tert-Butyl Ester Hydrochloride CAS 58620-93-2 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — β-Alanine tert-Butyl Ester Hydrochloride CAS 58620-93-2 Assay ≥98.0% (HPLC)

3-Chloro-D-Alanine Methyl Ester Hydrochloride CAS 112346-82-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3-Chloro-D-Alanine Methyl Ester Hydrochloride CAS 112346-82-4 Assay ≥98.0% (HPLC)

L-(-)-Histidinol Dihydrochloride CAS 1596-64-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-(-)-Histidinol Dihydrochloride CAS 1596-64-1 Assay ≥98.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.11.26 03:35:37
2022.11.04 07:53:24
2022.06.20 10:18:02
2022.06.03 11:31:02
2022.05.04 22:40:43
2021.11.17 16:41:42

related search